Eris Lifesciences Ltd
NSE:ERIS
Eris Lifesciences Ltd
NSE:ERIS
Price:
1 409.95
INR
0.32%
Market Cap:
192B
INR
Balance Sheet
Balance Sheet Decomposition
Eris Lifesciences Ltd
Eris Lifesciences Ltd
| Current Assets | 13.2B |
| Cash & Short-Term Investments | 1.9B |
| Receivables | 5.7B |
| Other Current Assets | 5.6B |
| Non-Current Assets | 57B |
| Long-Term Investments | 520.9m |
| PP&E | 5.2B |
| Intangibles | 47.8B |
| Other Non-Current Assets | 3.5B |
Balance Sheet
Eris Lifesciences Ltd
Eris Lifesciences Ltd
Currency: INR
Millions
Annual
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
50
|
89
|
23
|
106
|
75
|
673
|
369
|
509
|
560
|
942
|
|
| Cash |
50
|
89
|
23
|
106
|
75
|
673
|
369
|
509
|
560
|
942
|
|
| Short-Term Investments |
700
|
645
|
902
|
938
|
3 149
|
748
|
504
|
995
|
300
|
0
|
|
| Total Receivables |
298
|
349
|
640
|
1 135
|
1 412
|
2 108
|
2 189
|
2 713
|
4 593
|
5 717
|
|
| Accounts Receivables |
237
|
254
|
489
|
666
|
840
|
1 569
|
1 345
|
1 580
|
2 880
|
4 173
|
|
| Other Receivables |
61
|
95
|
151
|
469
|
572
|
539
|
844
|
1 133
|
1 714
|
1 544
|
|
| Inventory |
576
|
493
|
583
|
771
|
1 112
|
1 207
|
1 513
|
1 798
|
1 995
|
3 026
|
|
| Other Current Assets |
11
|
18
|
12
|
37
|
70
|
60
|
96
|
259
|
199
|
13 335
|
|
| Total Current Assets |
1 635
|
1 593
|
2 160
|
2 987
|
5 818
|
4 796
|
4 670
|
6 273
|
7 647
|
23 021
|
|
| PP&E Net |
675
|
707
|
558
|
526
|
561
|
873
|
779
|
1 919
|
3 774
|
5 237
|
|
| PP&E Gross |
675
|
0
|
558
|
526
|
561
|
873
|
779
|
1 919
|
3 774
|
5 237
|
|
| Accumulated Depreciation |
315
|
0
|
208
|
390
|
544
|
577
|
978
|
750
|
934
|
1 450
|
|
| Intangible Assets |
7
|
7
|
1 382
|
6 250
|
6 136
|
6 985
|
6 841
|
6 596
|
18 806
|
29 623
|
|
| Goodwill |
36
|
0
|
378
|
935
|
936
|
935
|
935
|
935
|
3 318
|
8 612
|
|
| Note Receivable |
92
|
149
|
159
|
181
|
154
|
123
|
539
|
71
|
57
|
657
|
|
| Long-Term Investments |
973
|
1 544
|
2 131
|
2 716
|
409
|
32
|
2 436
|
4 208
|
67
|
155
|
|
| Other Long-Term Assets |
156
|
187
|
499
|
1 006
|
1 523
|
1 780
|
2 148
|
2 720
|
3 004
|
3 183
|
|
| Other Assets |
36
|
0
|
378
|
935
|
936
|
935
|
935
|
935
|
3 318
|
8 612
|
|
| Total Assets |
3 573
N/A
|
4 186
+17%
|
7 267
+74%
|
14 601
+101%
|
15 537
+6%
|
15 523
0%
|
18 348
+18%
|
22 721
+24%
|
36 673
+61%
|
70 488
+92%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
367
|
246
|
385
|
908
|
841
|
1 001
|
1 026
|
1 178
|
1 248
|
2 683
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
27
|
102
|
|
| Short-Term Debt |
24
|
32
|
71
|
3
|
0
|
8
|
0
|
0
|
550
|
17 488
|
|
| Current Portion of Long-Term Debt |
5
|
5
|
2
|
1 026
|
1 761
|
120
|
23
|
40
|
1 383
|
3 409
|
|
| Other Current Liabilities |
259
|
407
|
300
|
318
|
452
|
518
|
620
|
779
|
1 224
|
1 637
|
|
| Total Current Liabilities |
655
|
690
|
758
|
2 255
|
3 055
|
1 647
|
1 669
|
1 996
|
4 432
|
25 321
|
|
| Long-Term Debt |
5
|
0
|
5
|
2 742
|
3
|
61
|
44
|
804
|
6 834
|
6 915
|
|
| Deferred Income Tax |
0
|
0
|
347
|
523
|
517
|
506
|
495
|
461
|
2 576
|
5 428
|
|
| Minority Interest |
39
|
32
|
238
|
247
|
183
|
0
|
0
|
1
|
247
|
6 359
|
|
| Other Liabilities |
213
|
256
|
248
|
222
|
273
|
345
|
374
|
378
|
624
|
604
|
|
| Total Liabilities |
912
N/A
|
977
+7%
|
1 595
+63%
|
5 988
+275%
|
4 031
-33%
|
2 560
-36%
|
2 584
+1%
|
3 638
+41%
|
14 713
+304%
|
44 627
+203%
|
|
| Equity | |||||||||||
| Common Stock |
1
|
1
|
138
|
138
|
138
|
136
|
136
|
136
|
136
|
136
|
|
| Retained Earnings |
2 659
|
3 207
|
5 534
|
8 476
|
11 354
|
12 828
|
15 628
|
18 841
|
21 673
|
25 544
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
13
|
0
|
0
|
106
|
151
|
181
|
|
| Total Equity |
2 660
N/A
|
3 208
+21%
|
5 671
+77%
|
8 613
+52%
|
11 505
+34%
|
12 963
+13%
|
15 764
+22%
|
19 083
+21%
|
21 960
+15%
|
25 861
+18%
|
|
| Total Liabilities & Equity |
3 573
N/A
|
4 186
+17%
|
7 267
+74%
|
14 601
+101%
|
15 537
+6%
|
15 523
0%
|
18 348
+18%
|
22 721
+24%
|
36 673
+61%
|
70 488
+92%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
138
|
138
|
138
|
138
|
138
|
136
|
136
|
136
|
136
|
136
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
